For: | Ilic I, Ilic M. International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis. World J Gastroenterol 2022; 28(32): 4698-4715 [PMID: 36157927 DOI: 10.3748/wjg.v28.i32.4698] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i32/4698.htm |
Number | Citing Articles |
1 |
Fábio França Vieira e Silva, Andrea Ballini, Marina Di Domenico, María Elena Padín-Iruegas. The Complexity of the Pancreatic Lymphatic System and the Key Role of Para-Aortic Lymph Node Metastasis in Pancreatic Cancer Prognosis Prediction: A Comprehensive Review. Anatomia 2024; 3(2): 124 doi: 10.3390/anatomia3020010
|
2 |
Michal Alexovič, Csilla Uličná, Ján Sabo, Katarina Davalieva. Human peripheral blood mononuclear cells as a valuable source of disease‐related biomarkers: Evidence from comparative proteomics studies. PROTEOMICS – Clinical Applications 2024; 18(2) doi: 10.1002/prca.202300072
|
3 |
Sara Calistri, Giuseppe Ottaviano, Alberto Ubaldini. Radiopharmaceuticals for Pancreatic Cancer: A Review of Current Approaches and Future Directions. Pharmaceuticals 2024; 17(10): 1314 doi: 10.3390/ph17101314
|
4 |
Qi Li, Ruiyun Zheng, Yinfeng Han, Musheng Ye, Yongkai Diao, Junhui Huang. Application of Intelligent Digital Technology in Load Forecasting of New Power Systems. 2023 International Conference on Network, Multimedia and Information Technology (NMITCON) 2023; : 1 doi: 10.1109/NMITCON58196.2023.10276027
|
5 |
Sanjeev Dhawan, Ashona Singh, Neha Manhas, Pule Seboletswe, Lungisani Khubone, Gobind Kumar, Sreekantha B. Jonnalagadda, Asif Raza, Arun K. Sharma, Parvesh Singh. Exploring Novel Coumarin‐Tethered Bis‐Triazoles: Apoptosis Induction in Human Pancreatic Cancer Cells, Antimicrobial Effects, and Molecular Modelling Investigations. ChemMedChem 2024; 19(22) doi: 10.1002/cmdc.202400297
|
6 |
Elena Orlandi, Massimo Guasconi, Stefano Vecchia, Serena Trubini, Mario Giuffrida, Manuela Proietto, Elisa Anselmi, Patrizio Capelli, Andrea Romboli. Exploring the Horizon: Anti-Fibroblast Growth Factor Receptor Therapy in Pancreatic Cancer with Aberrant Fibroblast Growth Factor Receptor Expression—A Scoping Review. Cancers 2024; 16(16): 2912 doi: 10.3390/cancers16162912
|
7 |
Gretchen Murray, Mitchell L. Ramsey, Phil A. Hart, Kristen M. Roberts. Fat malabsorption in pancreatic cancer: Pathophysiology and management. Nutrition in Clinical Practice 2024; 39(S1) doi: 10.1002/ncp.11129
|
8 |
Eden Demere Amare, Sumi Lee, Dongho Choi, Ji Hyun Shin, Kyeong Geun Lee, Kyeong Sik Kim, Hyunsung Kim, Yun Kyung Jung. Exploring the prognostic role of cluster of differentiation 47 in patients with advanced pancreatic cancer: a comparative cohort study. Annals of Surgical Treatment and Research 2025; 108(2): 98 doi: 10.4174/astr.2025.108.2.98
|
9 |
Luis Fernando Méndez-López, Ana Laura de la Garza Hernández, Manuel López-Cabanillas Lomelí. . Interdisciplinary Cancer Research 2024; doi: 10.1007/16833_2024_324
|
10 |
Bani Dhother, Mia Rajan, Ananya Kurri, Asma Mohammed, Amil Dudhia, Fangshouh Cheng, Riyaz Basha. Immune Therapy for Pancreatic and Colon Cancers. 2025; : 291 doi: 10.1016/B978-0-443-24742-2.00023-X
|
11 |
Xi Liu, Ana Jimenez-Alesanco, Zexian Li, Bruno Rizzuti, José L. Neira, Matías Estaras, Ling Peng, Eduardo Chuluyan, Juan Garona, Florencia Gottardo, Adrián Velazquez-Campoy, Yi Xia, Olga Abian, Patricia Santofimia-Castaño, Juan Iovanna. Development of an efficient NUPR1 inhibitor with anticancer activity. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-79340-z
|
12 |
Seema Kumari, Sujatha Peela, Ganji Purnachandra Nagaraju, Mundla Srilatha. Polysaccharides as therapeutic vehicles in pancreatic cancer. Drug Discovery Today 2025; 30(3): 104320 doi: 10.1016/j.drudis.2025.104320
|
13 |
Iuliia S. Zakharenkova, Victoria E. Khoronenko, Vladimir S. Trifanov. Comparative evaluation of the perioperative anesthesia methods for cancer patients undergoing pancreaticoduodenectomy. Russian Journal of Oncology 2023; 28(2): 137 doi: 10.17816/onco623528
|
14 |
Sara Long, Miquel Porta, Jeffrey Yang, Xiaohong Jing, Magda Gasull, Gabriela Burgos, Diane Simeone, Leonardo Trasande. Concentrations of Per-and Polyfluoroalkyl Substances (PFAS) and Pancreatic Cancer: A Case–Control Study in New York. Exposure and Health 2025; 17(1): 293 doi: 10.1007/s12403-024-00661-5
|
15 |
Fahrul Nurkolis, Dionysius Subali, Nurpudji Astuti Taslim, Nelly Mayulu, Hardinsyah Hardinsyah, Raymond Rubianto Tjandrawinata, Bonglee Kim. . Interdisciplinary Cancer Research 2024; doi: 10.1007/16833_2024_212
|
16 |
Arunima Maiti, Susmita Mondal, Sounetra Choudhury, Arnab Bandopadhyay, Sanghamitra Mukherjee, Nilabja Sikdar. Oncometabolites in pancreatic cancer: Strategies and its implications. World Journal of Experimental Medicine 2024; 14(4): 96005 doi: 10.5493/wjem.v14.i4.96005
|
17 |
Hongkyung Kim, Jinho Lee, Mi Ri Park, Zisun Choi, Seung Jung Han, Dongha Kim, Saeam Shin, Seung-Tae Lee, Jong Rak Choi, Seung Woo Park. Prognostic Value of Residual Circulating Tumor DNA in Metastatic Pancreatic Ductal Adenocarcinoma. Annals of Laboratory Medicine 2025; 45(2): 199 doi: 10.3343/alm.2024.0345
|
18 |
Won Jae Yoon. Public Fear of Pancreatic Diseases: Causes and Clinical Outcomes at a Single Korean Center. Gut and Liver 2024; 18(4): 756 doi: 10.5009/gnl240241
|
19 |
Fakhrddine Amri, Hajar Koulali, Rachid Jabi, Abdelkrim Zazour, Mohammed Bouziane, Zahi Ismaili, Ghizlane Kharrasse. Pancreatic cancer: experience from an emerging country in North Africa. Journal of Cancer Research and Clinical Oncology 2023; 149(15): 14297 doi: 10.1007/s00432-023-05245-5
|
20 |
Pankaj Kumar Panda, Daniel Shao-Weng Tan. International Encyclopedia of Public Health. 2025; : 136 doi: 10.1016/B978-0-323-99967-0.00259-3
|
21 |
Steven Grewe, Markus S. Jördens, Christoph Roderburg, Catherine Leyh, Simon Labuhn, Tom Luedde, Sarah Krieg, Andreas Krieg, Sven H. Loosen, Karel Kostev. Elevated HbA1c Levels Are Associated with a Risk of Pancreatic Cancer: A Case–Control Study. Journal of Clinical Medicine 2024; 13(18): 5584 doi: 10.3390/jcm13185584
|
22 |
Hanns Lembach Jahnsen. Prevención y detección precoz del cáncer de páncreas. Revista Médica Clínica Las Condes 2024; 35(2): 106 doi: 10.1016/j.rmclc.2024.03.001
|
23 |
Ga Hyun Lee, Yeon Hee Kim, Sang Myung Woo, Woo Jin Lee, Sung-Sik Han, Sang-Jae Park, Sherry Price, Penias Tembo, James R. Hébert, Mi Kyung Kim. The Impact of the Dietary Inflammatory Index, Fasting Blood Glucose, and Smoking Status on the Incidence and Survival of Pancreatic Cancer: A Retrospective Case–Control Study and a Prospective Study. Nutrients 2024; 16(22): 3941 doi: 10.3390/nu16223941
|
24 |
Hussein Hassan Okasha, Mohammed Tag-Adeen, Hossam Eldin Shaaban. Role of pancreatic juice cytology in diagnosis of high-grade pancreatic intraepithelial neoplasia. World Journal of Clinical Cases 2025; 13(10): 94437 doi: 10.12998/wjcc.v13.i10.94437
|
25 |
Friedrich L. Pietsch, Florian Haag, Isabelle Ayx, Freba Grawe, Abhinay K. Vellala, Stefan O. Schoenberg, Matthias F. Froelich, Hishan Tharmaseelan. Textural heterogeneity of liver lesions in CT imaging - comparison of colorectal and pancreatic metastases. Abdominal Radiology 2024; 49(12): 4295 doi: 10.1007/s00261-024-04511-5
|
26 |
Emre Basar, Henry Mead, Bennett Shum, Ingrid Rauter, Cihan Ay, Adriane Skaletz-Rorowski, Norbert H. Brockmeyer. Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A/B. Pharmaceutics 2024; 16(9): 1207 doi: 10.3390/pharmaceutics16091207
|
27 |
Paola Di Carlo, Nicola Serra, Teresa Maria Assunta Fasciana, Anna Giammanco, Francesco D’Arpa, Teresa Rea, Maria Santa Napolitano, Alessandro Lucchesi, Antonio Cascio, Consolato Maria Sergi, Massimiliano Galdiero. Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer. PLOS ONE 2024; 19(2): e0294049 doi: 10.1371/journal.pone.0294049
|
28 |
Nasr Eldin Elwali, Saad Mohammed AlShareef, Ammar H. Khamis, Moawia M. A. Elhassan. Pancreatic cancer in Saudi Arabia (2005–2020): increasing trend. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12401-8
|
29 |
Frederik J. Hansen, Anke Mittelstädt, Finn-Niklas Clausen, Samuel Knoedler, Leonard Knoedler, Sebastian Klöckner, Isabelle Kuchenreuther, Johanne Mazurie, Lisa-Sophie Arnold, Anna Anthuber, Anne Jacobsen, Susanne Merkel, Nadine Weisel, Bettina Klösch, Alara Karabiber, Irem Tacyildiz, Franziska Czubayko, Helena Reitberger, Amr El Gendy, Maximilian Brunner, Christian Krautz, Kerstin Wolff, Sidonia Mihai, Clemens Neufert, Jürgen Siebler, Robert Grützmann, Georg F. Weber, Paul David. CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patients. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70916-3
|
30 |
Klára Gotvaldová, Jitka Špačková, Jiří Novotný, Kamila Baslarová, Petr Ježek, Lenka Rossmeislová, Jan Gojda, Katarína Smolková. BCAA metabolism in pancreatic cancer affects lipid balance by regulating fatty acid import into mitochondria. Cancer & Metabolism 2024; 12(1) doi: 10.1186/s40170-024-00335-5
|
31 |
Shaofei Chang, Yiping Zou, Jing Huang, Zhifei Li, Yuexiang Liang, Song Gao. Fibrinogen to pre-albumin ratio is an independent prognostic index for patients with pancreatic ductal adenocarcinoma after radical resection. World Journal of Surgical Oncology 2024; 22(1) doi: 10.1186/s12957-024-03524-0
|
32 |
Abdul Salam, Asif Ali, Umar Nishan, Noaman Khan, Mohamed A. Ibrahim, Zafar Iqbal, Nawshad Muhammad, Anum Fayyaz, Fawad Muhammad, Abdul Mateen, Zhiyuan Wu, Saifullah Afridi. Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients. ACS Pharmacology & Translational Science 2024; 7(11): 3585 doi: 10.1021/acsptsci.4c00490
|
33 |
Liudmila G. Zhukova, Dmitry S. Bordin, Elena A. Dubtsova, Matvey A. Ilin, Mariia A. Kiriukova, Polina S. Feoktistova, Vyacheslav I. Egorov. How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review. Journal of Modern Oncology 2024; 25(4) doi: 10.26442/18151434.2023.4.202541
|
34 |
Prateek Suresh Harne, Vaishali Harne, Curtis Wray, Nirav Thosani. Endoscopic innovations in diagnosis and management of pancreatic cancer: a narrative review and future directions. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241297434
|
35 |
Raoof Nopour. Prediction of 12-month recurrence of pancreatic cancer using machine learning and prognostic factors. BMC Medical Informatics and Decision Making 2024; 24(1) doi: 10.1186/s12911-024-02766-y
|
36 |
O. O. Pidmurniak, M. B. Tsvihun, Y. S. Kravchuk, O. O. Pidmurniak . Radical surgical treatment methods for pancreatic tumors. Reports of Vinnytsia National Medical University 2024; 28(4): 688 doi: 10.31393/reports-vnmedical-2024-28(4)-18
|
37 |
Isaac Baffour Senkyire, Kashala Kabe Gedeon, Emmanuel Freeman, Benjamin Ghansah, Zhe Liu. EcD-Net: Encoder-Corollary Atrous Spatial Pyramid Pooling-decoder network for automated pancreas segmentation of 2D CT images. Informatics in Medicine Unlocked 2024; 51: 101597 doi: 10.1016/j.imu.2024.101597
|
38 |
Lakshmi Sai Niharika Janga, Hembashima G Sambe, Mohamed Yasir, Ruzhual K Man, Amaresh Gogikar, Ankita Nanda, Lubna Mohammed. Holistic Understanding of the Role of Carbohydrate Antigen 19-9 in Pancreatic Cancer Screening, Early Diagnosis, and Prognosis: A Systematic Review. Cureus 2023; doi: 10.7759/cureus.44382
|
39 |
Anamarija Abu el Rub, Maja D. Nešić, Tanja Dučić, Marija Radoičić, Mirjana Novaković, Jelena Žakula, Vanja Ralić, Marijana Petković, Milutin Stepić. Synchrotron radiation-FTIR biomolecular assessment in PANC-1 and MIA PaCa-2 pancreatic cancer cells after treatment with Gd-TiO2 nanoparticles. Journal of Molecular Structure 2024; 1309: 138167 doi: 10.1016/j.molstruc.2024.138167
|
40 |
Magdalena Holze, Azaz Ahmed, Martin Loos, Christoph W. Michalski, Rosa Klotz. Geschlechtsunterschiede beim Pankreaskarzinom. Die Chirurgie 2024; 95(9): 709 doi: 10.1007/s00104-024-02150-6
|
41 |
Yaohui Fang, Chunlu Tan, Zhenjiang Zheng, Jianchen Yang, Jiali Tang, Ruizhe Guo, Epiphane K. Silli, Zhe Chen, Jia Chen, Ruyu Ge, Yuquan Liu, Xiuqi Wen, Jingdan Liang, Yunfei Zhu, Yutong Jin, Qian Li, Ying Wang. The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Biochemical Pharmacology 2025; 236: 116849 doi: 10.1016/j.bcp.2025.116849
|
42 |
Elena M. Stoffel, Randall E. Brand, Michael Goggins. Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention. Gastroenterology 2023; 164(5): 752 doi: 10.1053/j.gastro.2023.02.012
|
43 |
Inés Díaz-Martínez, Rebeca Miranda-Castro, Noemí de-los-Santos-Álvarez, María Jesús Lobo-Castañón. Lectin-Mimicking Aptamer as a Generic Glycan Receptor for Sensitive Detection of Glycoproteins Associated with Cancer. Analytical Chemistry 2024; doi: 10.1021/acs.analchem.3c05891
|
44 |
Toni T Seppälä, Richard A Burkhart, Bryson W Katona. Hereditary colorectal, gastric, and pancreatic cancer: comprehensive review. BJS Open 2023; 7(3) doi: 10.1093/bjsopen/zrad023
|
45 |
Balbina García-Reyes, Ivan Kuzmanov, Reiner Schneider, Bianca Schneiker, Patrik Efferz, Jörg C. Kalff, Sven Wehner. Glial cell-derived soluble factors increase the metastatic potential of pancreatic adenocarcinoma cells and induce epithelial-to-mesenchymal transition. Journal of Cancer Research and Clinical Oncology 2023; 149(15): 14315 doi: 10.1007/s00432-023-05133-y
|
46 |
Jesi Kim, Tarub Mabud, Chenchan Huang, Juan Lloret del Hoyo, Robert Petrocelli, Abhinav Vij, Bari Dane. Inter-reader agreement of pancreatic adenocarcinoma resectability assessment with photon counting versus energy integrating detector CT. Abdominal Radiology 2024; 49(9): 3149 doi: 10.1007/s00261-024-04298-5
|
47 |
Alankar Roy, Sayan Sharma, Ishani Paul, Sujay Ray. Molecular hybridization assisted multi-technique approach for designing USP21 inhibitors to halt catalytic triad-mediated nucleophilic attack and suppress pancreatic ductal adenocarcinoma progression: A molecular dynamics study. Computers in Biology and Medicine 2024; 182: 109096 doi: 10.1016/j.compbiomed.2024.109096
|
48 |
Pojsakorn Danpanichkul, Ekdanai Uawithya, Chawin Lopimpisuth, Banthoon Sukphutanan, Narathorn Kulthamrongsri, Majd B. Aboona, Kwanjit Duangsonk, Sirimas Lau, Daniel M. Simadibrata, Hinda Daggag, Michael B. Wallace, Karn Wijarnpreecha. Early-onset pancreatic cancer and associated metabolic risk factors in the Middle East and North Africa: A 20-year analysis of the Global Burden of Disease Study. Indian Journal of Gastroenterology 2024; doi: 10.1007/s12664-024-01626-x
|
49 |
Melissa Heller, Derek A. Mann, Bryson W. Katona. Current Approaches of Pancreatic Cancer Surveillance in High-Risk Individuals. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-025-01184-1
|
50 |
Lucia Mangone, Francesco Marinelli, Isabella Bisceglia, Francesca Roncaglia, Fortunato Morabito, Cinzia Testa, Carmine Pinto, Antonino Neri. A Population-Based Analysis of the Cancer Incidence in Individuals under 50 in a Northern Italian Province: Focusing on Regional Disparities and Public Health Implications. International Journal of Environmental Research and Public Health 2024; 21(10): 1333 doi: 10.3390/ijerph21101333
|
51 |
Sofia Laila Wik, Wenxin Tian, Claire Chenwen Zhong, Apurva Sawhney, Mingjun Gao, Qinyao Yu, Fanyu Xue, Sze Chai Chan, Shui Hang Chow, Yusuff Adebayo Adebisi, Jinqiu Yuan, Don Eliseo Lucero‐Prisno, Martin C. S. Wong, Junjie Huang. Distribution, Risk Factors and Epidemiological Trends of Pancreatic Cancer Across Countries’ Income Levels: A Comprehensive Analysis. Cancer Reports 2025; 8(2) doi: 10.1002/cnr2.70154
|
52 |
Lucía Cayuela, Aurelio Cayuela Domínguez. Has the trend in pancreatic cancer mortality in Spain started to slow down?. Revista Española de Enfermedades Digestivas 2023; doi: 10.17235/reed.2023.9573/2023
|
53 |
Deepak Sherpally, Ashish Manne. Advancing Immunotherapy in Pancreatic Cancer: A Brief Review of Emerging Adoptive Cell Therapies. Cancers 2025; 17(4): 589 doi: 10.3390/cancers17040589
|
54 |
Tianli Zhang, Mengmeng Liu, Qing Liu, Gary Guishan Xiao. Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1068855
|
55 |
Tereza Hálková, Bohuš Bunganič, Eva Traboulsi, Marek Minárik, Miroslav Zavoral, Lucie Benešová. Prognostic Role of Specific KRAS Mutations Detected in Aspiration and Liquid Biopsies from Patients with Pancreatic Cancer. Genes 2024; 15(10): 1302 doi: 10.3390/genes15101302
|
56 |
Ellie T. Y. Mok, Jessica L. Chitty, Thomas R. Cox. miRNAs in pancreatic cancer progression and metastasis. Clinical & Experimental Metastasis 2024; 41(3): 163 doi: 10.1007/s10585-023-10256-0
|
57 |
Syed Adnan Rahmat, Yutong He. Cancer Burden and Attributable Risk Factors of Cancers in China: Epidemiological Insights and Comparisons With India. Cancer Control 2024; 31 doi: 10.1177/10732748241276674
|
58 |
Kellie L. Bodeker, Brian J. Smith, Daniel J. Berg, Chandrikha Chandrasekharan, Saima Sharif, Naomi Fei, Sandy Vollstedt, Heather Brown, Meghan Chandler, Amanda Lorack, Stacy McMichael, Jared Wulfekuhle, Brett A. Wagner, Garry R. Buettner, Bryan G. Allen, Joseph M. Caster, Barbara Dion, Mandana Kamgar, John M. Buatti, Joseph J. Cullen. A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. Redox Biology 2024; 77: 103375 doi: 10.1016/j.redox.2024.103375
|
59 |
Nourhan G. Sallam, Nabila A. Boraie, Eman Sheta, Salma E. El-Habashy. Targeted delivery of genistein for pancreatic cancer treatment using hyaluronic-coated cubosomes bioactivated with frankincense oil. International Journal of Pharmaceutics 2024; 649: 123637 doi: 10.1016/j.ijpharm.2023.123637
|
60 |
Jiayi Wang, Yangjie Liao, Minzi Deng, Xing Wu, Xiaoyan Wang, Jingbo Li. 24-Hour Urinary Sodium Excretion Is Associated With Increased Risk of Pancreatic Cancer: A Prospective Cohort Study. Clinical and Translational Gastroenterology 2024; 15(10): e1 doi: 10.14309/ctg.0000000000000741
|
61 |
Ailen Suarez, Inés Marturano, Rocío Sánchez Canicoba, Marisa Canicoba. Update nutritional management in patients with pancreatic ductal adenocarcinoma: A literature reviews. Gastroenterology & Hepatology: Open access 2024; 15(2): 30 doi: 10.15406/ghoa.2024.15.00575
|
62 |
Wenkai Jiang, Caifei Xiang, Yan Du, Xiao Li, Xin Li, Wence Zhou. Time trend of pancreatic cancer mortality in the Western Pacific Region: age-period-cohort analysis from 1990 to 2019 and forecasting for 2044. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11369-1
|
63 |
Rana Muhammad Anss Bin Qadir, Musab Bin Umair, Umar Bin Tariq, Arslan Ahmad, Wajeeha Kiran, M Hasaan Shahid. Unraveling Pancreatic Cancer: Epidemiology, Risk Factors, and Global Trends. Cureus 2024; doi: 10.7759/cureus.72816
|
64 |
Qihong Wang, Jiao Liu, Zhuo Yang. Global, regional, and national burden of pancreatic cancer from 1990 to 2021, with projections for 25 years: a systematic analysis for the Global Burden of Disease Study 2021. European Journal of Cancer Prevention 2024; doi: 10.1097/CEJ.0000000000000942
|
65 |
Irena Ilic, Milena Ilic. Global Burden of Pancreatic Cancer Attributable to High Body-Mass Index in 204 Countries and Territories, 1990–2019. Cancers 2024; 16(4): 719 doi: 10.3390/cancers16040719
|
66 |
Jerry Xiao, Reetu Mukherji, George Sidarous, Shravanthy Suguru, Marcus Noel, Benjamin A. Weinberg, Aiwu He, Seema Agarwal. Longitudinal Circulating Tumor Cell Collection, Culture, and Characterization in Pancreatic Adenocarcinomas. Cancers 2025; 17(3): 355 doi: 10.3390/cancers17030355
|
67 |
Anna Han, Jiajing Liu, Pan Du, Wenxuan Li, Haiyan Quan, Zhenhua Lin, Liyan Chen. Taraxasterol regulates p53 transcriptional activity to inhibit pancreatic cancer by inducing MDM2 ubiquitination degradation. Phytomedicine 2025; 136: 156298 doi: 10.1016/j.phymed.2024.156298
|
68 |
Elen Baloyan, Davit Zohrabyan, Liana Safaryan, Armen Avagyan, Lilit Harutyunyan, Vardan Bardakhchyan, Jemma Arakelyan, Amalya Sargsyan, Martin Harutyunyan, Mariam Mailyan, Gevorg Tamamyan, Samvel Bardakhchyan. Treatment and Outcomes of Pancreatic Cancer in Armenia: A Retrospective Study From Resource-Limited Settings. JCO Global Oncology 2025; (11) doi: 10.1200/GO.24.00217
|
69 |
Saleh A Alessy, Eileen Morgan, Ali S Al-Zahrani, Mariam Zahwe, Heba Fouad, Freddie Bray, Ariana Znaor, Saleh A Alqahtani. Burden of five major types of gastrointestinal cancer in the Eastern Mediterranean Region. BMJ Open Gastroenterology 2025; 12(1): e001577 doi: 10.1136/bmjgast-2024-001577
|
70 |
Linda C. Chu, Elliot K. Fishman. Pancreatic ductal adenocarcinoma staging: a narrative review of radiologic techniques and advances. International Journal of Surgery 2024; 110(10): 6052 doi: 10.1097/JS9.0000000000000899
|
71 |
Muhammer Ergenç, Tevfik Kıvılcım Uprak, Ayşegül Bahar Özocak, Şakir Karpuz, Mümin Coşkun, Cumhur Yeğen, Ali Emre Atıcı. Pancreaticoduodenectomy in patients < 75 years versus ≥ 75 years old: a comparative study. Aging Clinical and Experimental Research 2024; 36(1) doi: 10.1007/s40520-024-02804-9
|
72 |
Safia Samir, Mohamed El-Ashry, Waleed Soliman, Marwa Hassan. Urinary biomarkers analysis as a diagnostic tool for early detection of pancreatic adenocarcinoma: Molecular quantification approach. Computational Biology and Chemistry 2024; 112: 108171 doi: 10.1016/j.compbiolchem.2024.108171
|
73 |
Solange R. Paredes-Moscosso, Amit C. Nathwani. 10 years of BiTE immunotherapy: an overview with a focus on pancreatic cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1429330
|
74 |
Umar Hayat, Phillip S. Croce, Aseel Saadeh, Karna Desai, John Appiah, Sidrah Khan, Yakub I. Khan, Kishore Kumar, Ahmad Hanif. Current and Emerging Treatment Options for Pancreatic Cancer: A Comprehensive Review. Journal of Clinical Medicine 2025; 14(4): 1129 doi: 10.3390/jcm14041129
|